A new drug for Crohn's disease

被引：0
|
作者：
Aschenbrenner, Diane S.
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2008年 / 108卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：33 / 34
页数：2
相关论文
共 50 条
  • [1] Methotrexate in Crohn's disease: a new face for an old drug?
    Cesarini, Monica
    Festa, Stefano
    Papi, Claudio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (10) : 1135 - 1144
  • [2] Drug treatment for Crohn's disease
    Yacyshyn, BR
    LANCET, 1998, 352 (9129): : 743 - 743
  • [3] The Success Rate of New Drug Development in Clinical Trials: Crohn's Disease
    Parker, Jayson L.
    Kohler, Jillian Clare
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2010, 13 (02): : 191 - 197
  • [4] Psoriasis drug may find new indication for Crohn's disease treatment
    McCarthy, Jacob
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 657 - 657
  • [5] Drug safety in the treatment of Crohn's disease
    Juillerat, P
    Felley, C
    Mottet, C
    Froehlich, F
    Vader, JP
    Burnand, B
    Gonvers, JJ
    Michetti, P
    DIGESTION, 2005, 71 (01) : 8 - 12
  • [6] Therapeutic drug monitoring in Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (03): : 150 - 150
  • [7] Drug safety in Crohn's disease therapy
    Juillerat, Pascal
    Pittet, Valerie
    Felley, Christian
    Mottet, Christian
    Froehlich, Florian
    Vader, John-Paul
    Gonvers, Jean-Jacques
    Michetti, Pierre
    DIGESTION, 2007, 76 (02) : 161 - 168
  • [8] New Biomarkers for Crohn's Disease
    Bernstein, Charles N.
    GASTROENTEROLOGY, 2020, 159 (01) : 30 - 32
  • [9] A Drug Reaction to Ustekinumab in a Patient With Crohn's Disease
    Yabumoto, Maya
    Wong, Kimberly
    Parekh, Nimisha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1202 - S1202
  • [10] Therapeutic Drug Monitoring of Biologics in Crohn?s Disease
    Grossberg, Laurie B.
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 299 - 317
12345